The most harmful industrial ingredients contributing to dementia risk are processed meat preservatives (nitrites/nitrates), added sugars (high-fructose corn syrup), and chemical additives like emulsifiers. Rather than focusing on a single nutrient, public health studiesโincluding recent 2026 data from the Harvard T.H. Chan School of Public Healthโpoint to specific chemical formulations and industrial ingredients that directly […]
Archive for the ‘Regulatory Medical Writing’ Category
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐ฆ๐จ๐ฌ๐ญ ๐ก๐๐ซ๐ฆ๐๐ฎ๐ฅ ๐๐จ๐จ๐ ๐ข๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ๐ฌ ๐ญ๐ก๐๐ญ ๐๐จ๐ง๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ ๐ญ๐จ ๐๐๐ฆ๐๐ง๐ญ๐ข๐ ๐ซ๐ข๐ฌ๐ค?
Posted by Michael A. S. Guth on June 10th, 2026
Posted in Neuroplasticity, Regulatory Medical Writing 
Comments Off on ๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐ฆ๐จ๐ฌ๐ญ ๐ก๐๐ซ๐ฆ๐๐ฎ๐ฅ ๐๐จ๐จ๐ ๐ข๐ง๐ ๐ซ๐๐๐ข๐๐ง๐ญ๐ฌ ๐ญ๐ก๐๐ญ ๐๐จ๐ง๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ ๐ญ๐จ ๐๐๐ฆ๐๐ง๐ญ๐ข๐ ๐ซ๐ข๐ฌ๐ค?Demystifying Long-Horizon Survival Forecasting in Oncology HTAโPerspective Manuscript
Posted by Michael A. S. Guth on June 9th, 2026
Dear Drs. xxxxxxxxxxxx and xxxxxxxxxxxxxxx, I write to inquire whether the Journal of Clinical Epidemiology would consider a Perspective manuscript entitled xxxxxxxxxxxxxxxxxxxxxxxx. The manuscript (~5,100 words, 37 references) addresses a problem that experienced clinical epidemiologists and HTA reviewers recognize but that the published literature has been reluctant to name directly: when Phase 3 trials produce […]
Posted in Pharma and Medical Device, Regulatory Medical Writing Comments Off on Demystifying Long-Horizon Survival Forecasting in Oncology HTAโPerspective ManuscriptAdeno-associated virus serotype 9 (AAV9): tool of gene therapy that crosses the BBB
Posted by Michael A. S. Guth on June 4th, 2026
Adeno-associated virus serotype 9 (AAV9) is highly valued in gene therapy because it can cross the blood-brain barrier. It is primarily used to treat monogenic neurological and neuromuscular disorders, most notably Spinal Muscular Atrophy (SMA). AAV9 vectors deliver functional genetic material to replace or suppress faulty genes. Approved treatments and advanced clinical trials using AAV9 […]
Posted in Pharma and Medical Device, Regulatory Medical Writing Comments Off on Adeno-associated virus serotype 9 (AAV9): tool of gene therapy that crosses the BBBHEOR Survival Statistics and Data Shading
Posted by Michael A. S. Guth on June 4th, 2026
๐๐ก๐๐ง ๐ ๐๐ซ๐ฎ๐ ๐ฌ๐ก๐จ๐ฐ๐ฌ ๐ ๐ก๐๐ณ๐๐ซ๐ ๐ซ๐๐ญ๐ข๐จ ๐จ๐ ๐.๐๐ โ ๐ฐ๐ก๐ข๐๐ก ๐ฌ๐จ๐ฎ๐ง๐๐ฌ ๐ข๐ฆ๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐ฏ๐ โ ๐๐ง๐ ๐ญ๐ก๐ ๐ญ๐ซ๐ข๐๐ฅ ๐ฆ๐๐๐ข๐๐ง ๐ฌ๐ฎ๐ซ๐ฏ๐ข๐ฏ๐๐ฅ ๐ฐ๐๐ฌ ๐๐ ๐ฆ๐จ๐ง๐ญ๐ก๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐จ๐ง๐ญ๐ซ๐จ๐ฅ ๐๐ซ๐ฆ, ๐ญ๐ก๐ ๐ฆ๐๐ญ๐ก ๐ฐ๐จ๐ซ๐ค๐ฌ ๐จ๐ฎ๐ญ ๐ญ๐จ ๐ซ๐จ๐ฎ๐ ๐ก๐ฅ๐ฒ ๐ ๐๐๐๐ข๐ญ๐ข๐จ๐ง๐๐ฅ ๐ฆ๐จ๐ง๐ญ๐ก๐ฌ ๐๐ญ ๐ญ๐ก๐ ๐ฆ๐๐๐ข๐๐ง. ๐๐จ๐ญ ๐ฒ๐๐๐ซ๐ฌ. ๐๐จ๐ง๐ญ๐ก๐ฌ. ๐๐จ๐ฆ๐๐ญ๐ข๐ฆ๐๐ฌ ๐ฐ๐๐๐ค๐ฌ. The drug costs $28,000/month. If a cancer drug showed “statistically significant survival […]
ย ๐๐ฎ๐ฉ๐ฉ๐ฅ๐๐ฆ๐๐ง๐ญ ๐๐ฒ๐ญ๐ก๐ฌ: ๐๐ก๐ ๐๐ซ๐ฎ๐ญ๐ก ๐๐๐จ๐ฎ๐ญ ๐๐ข๐๐๐ข๐ง๐๐ฆ๐ข๐๐ ๐๐ง๐ ๐๐ค๐ข๐ง ๐๐ซ๐จ๐ญ๐๐๐ญ๐ข๐จ๐ง
Posted by Michael A. S. Guth on May 17th, 2026
Niacinamide is currently one of the most celebrated ingredients in skincare, praised in every beauty and wellness journal for its ability to strengthen the skin barrier topically. But lately, there has been a lot of buzz about taking it orally to prevent skin cancer. Does the science back up the hype? Yesโbut with some major […]
Posted in Regulatory Medical Writing Comments Off on ย ๐๐ฎ๐ฉ๐ฉ๐ฅ๐๐ฆ๐๐ง๐ญ ๐๐ฒ๐ญ๐ก๐ฌ: ๐๐ก๐ ๐๐ซ๐ฎ๐ญ๐ก ๐๐๐จ๐ฎ๐ญ ๐๐ข๐๐๐ข๐ง๐๐ฆ๐ข๐๐ ๐๐ง๐ ๐๐ค๐ข๐ง ๐๐ซ๐จ๐ญ๐๐๐ญ๐ข๐จ๐งReal-World Evidence vs. Meta-Analyses: The Evolving Debate on Nicotinamide for Skin Cancer Chemoprevention
Posted by Michael A. S. Guth on May 17th, 2026
Real-World Evidence vs. Meta-Analyses: The Evolving Debate on Nicotinamide for Skin Cancer Chemoprevention The clinical utility of oral nicotinamide (NAM) for non-melanoma skin cancer (NMSC) chemoprevention remains a prime example of the tension between landmark RCT data, real-world evidence (RWE), and systematic evidence syntheses. While the 2015 Phase 3 ONTRAC trial established a 23% reduction […]
Posted in Regulatory Medical Writing Comments Off on Real-World Evidence vs. Meta-Analyses: The Evolving Debate on Nicotinamide for Skin Cancer Chemoprevention๐๐ฟ๐ผ๐บ ๐ข๐ฏ๐๐ฒ๐ฟ๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ผ ๐๐ผ๐ป๐๐ฟ๐ผ๐น: ๐ง๐ต๐ฒ ๐ก๐ฒ๐ ๐๐ฟ๐ฎ ๐ผ๐ณ ๐๐ผ๐บ๐ฝ๐๐๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ก๐ฒ๐๐ฟ๐ผ๐๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ.
Posted by Michael A. S. Guth on May 7th, 2026
๐ช๐ต๐ ๐๐ต๐ฒ ๐๐๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐๐ถ๐ผ๐๐ฒ๐ฐ๐ต ๐๐ฒ๐ฝ๐ฒ๐ป๐ฑ๐ ๐ผ๐ป ๐๐ฟ๐ถ๐ฑ๐ด๐ถ๐ป๐ด “๐ช๐ฒ๐๐๐ฎ๐ฟ๐ฒ” ๐ฎ๐ป๐ฑ ๐ฆ๐ผ๐ณ๐๐๐ฎ๐ฟ๐ฒ.๐ง๐ต๐ฒ ๐ก๐ฒ๐ ๐ ๐๐ฒ๐ฎ๐ฝ ๐ถ๐ป ๐๐: ๐๐ฟ๐ผ๐๐ป๐ฑ๐ถ๐ป๐ด ๐ ๐ฎ๐ฐ๐ต๐ถ๐ป๐ฒ ๐๐ฒ๐ฎ๐ฟ๐ป๐ถ๐ป๐ด ๐ถ๐ป ๐๐ถ๐ผ๐น๐ผ๐ด๐ถ๐ฐ๐ฎ๐น ๐ฃ๐ต๐๐๐ถ๐ฐ๐. ๐๐ฟ๐ผ๐บ ๐ข๐ฏ๐๐ฒ๐ฟ๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ผ ๐๐ผ๐ป๐๐ฟ๐ผ๐น: ๐ง๐ต๐ฒ ๐ก๐ฒ๐ ๐๐ฟ๐ฎ ๐ผ๐ณ ๐๐ผ๐บ๐ฝ๐๐๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ก๐ฒ๐๐ฟ๐ผ๐๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ. The future of AI and biotech isn’t just about collecting more data; itโs about building better models of the underlying “physics” of the system. […]
Posted in Regulatory Medical Writing Comments Off on ๐๐ฟ๐ผ๐บ ๐ข๐ฏ๐๐ฒ๐ฟ๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ผ ๐๐ผ๐ป๐๐ฟ๐ผ๐น: ๐ง๐ต๐ฒ ๐ก๐ฒ๐ ๐๐ฟ๐ฎ ๐ผ๐ณ ๐๐ผ๐บ๐ฝ๐๐๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ก๐ฒ๐๐ฟ๐ผ๐๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ.๐ง๐ต๐ฒ ๐ ๐ฎ๐๐ต๐ฒ๐บ๐ฎ๐๐ถ๐ฐ๐ฎ๐น ๐๐ฟ๐ฐ๐ต๐ถ๐๐ฒ๐ฐ๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐ก๐ฒ๐๐ฟ๐ผ๐ฝ๐น๐ฎ๐๐๐ถ๐ฐ๐ถ๐๐: ๐๐ป๐๐ฒ๐ด๐ฟ๐ฎ๐๐ถ๐ป๐ด ๐๐ ๐ ๐ผ๐ฑ๐ฒ๐น๐ ๐๐ถ๐๐ต ๐ ๐ผ๐ฑ๐ฒ๐ฟ๐ป ๐ ๐
Posted by Michael A. S. Guth on May 7th, 2026
๐ง๐ต๐ฒ ๐ ๐ฎ๐๐ต๐ฒ๐บ๐ฎ๐๐ถ๐ฐ๐ฎ๐น ๐๐ฟ๐ฐ๐ต๐ถ๐๐ฒ๐ฐ๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐ก๐ฒ๐๐ฟ๐ผ๐ฝ๐น๐ฎ๐๐๐ถ๐ฐ๐ถ๐๐: ๐๐ป๐๐ฒ๐ด๐ฟ๐ฎ๐๐ถ๐ป๐ด ๐๐ ๐ ๐ผ๐ฑ๐ฒ๐น๐ ๐๐ถ๐๐ต ๐ ๐ผ๐ฑ๐ฒ๐ฟ๐ป ๐ ๐. ๐๐ฒ๐๐ผ๐ป๐ฑ ๐๐ต๐ฒ ๐ฆ๐ถ๐ป๐ด๐น๐ฒ ๐ก๐ฒ๐๐ฟ๐ผ๐ป: ๐ ๐จ๐ป๐ถ๐ณ๐ถ๐ฒ๐ฑ ๐๐ถ๐ฒ๐ฟ๐ฎ๐ฟ๐ฐ๐ต๐ ๐ณ๐ผ๐ฟ ๐ ๐๐น๐๐ถ๐๐ฐ๐ฎ๐น๐ฒ ๐ก๐ฒ๐๐ฟ๐ฎ๐น ๐ ๐ผ๐ฑ๐ฒ๐น๐ถ๐ป๐ด. ๐๐ฟ๐ถ๐ฑ๐ด๐ถ๐ป๐ด ๐๐ต๐ฒ ๐๐ฎ๐ฝ:ย ๐๐ฟ๐ผ๐บ ๐๐ฒ๐๐ฒ๐ฟ๐บ๐ถ๐ป๐ถ๐๐๐ถ๐ฐ ๐ข๐๐๐ ๐๐ผ ๐ฆ๐๐ผ๐ฐ๐ต๐ฎ๐๐๐ถ๐ฐ ๐ฃ๐ผ๐ฝ๐๐น๐ฎ๐๐ถ๐ผ๐ป ๐๐๐ป๐ฎ๐บ๐ถ๐ฐ๐. Large neuronal networks exhibit complex dynamics across multiple scales, from single-neuron excitability to whole-brain rhythms. At the Institute, we are examining how a unified […]
Posted in Regulatory Medical Writing Comments Off on ๐ง๐ต๐ฒ ๐ ๐ฎ๐๐ต๐ฒ๐บ๐ฎ๐๐ถ๐ฐ๐ฎ๐น ๐๐ฟ๐ฐ๐ต๐ถ๐๐ฒ๐ฐ๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐ก๐ฒ๐๐ฟ๐ผ๐ฝ๐น๐ฎ๐๐๐ถ๐ฐ๐ถ๐๐: ๐๐ป๐๐ฒ๐ด๐ฟ๐ฎ๐๐ถ๐ป๐ด ๐๐ ๐ ๐ผ๐ฑ๐ฒ๐น๐ ๐๐ถ๐๐ต ๐ ๐ผ๐ฑ๐ฒ๐ฟ๐ป ๐ ๐๐๐๐๐จ๐๐ข๐ง๐ ๐๐ง๐๐๐ซ๐ญ๐๐ข๐ง๐ญ๐ฒ: ๐๐ฌ๐ข๐ง๐ ๐๐ญ๐จ๐๐ก๐๐ฌ๐ญ๐ข๐ ๐๐ช๐ฎ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ญ๐จ ๐๐ง๐๐๐ซ๐ฌ๐ญ๐๐ง๐ ๐ญ๐ก๐ ๐๐ซ๐๐ข๐งโ๐ฌ ๐๐ก๐๐จ๐ฌ
Posted by Michael A. S. Guth on May 7th, 2026
๐๐ซ๐๐๐ซ ๐๐ซ๐จ๐ฆ ๐๐ก๐๐จ๐ฌ: ๐๐จ๐ฐ ๐๐๐ง๐๐จ๐ฆ๐ง๐๐ฌ๐ฌ ๐๐ซ๐ข๐ฏ๐๐ฌ ๐๐๐ฎ๐ซ๐๐ฅ ๐๐๐๐ซ๐ง๐ข๐ง๐ ๐๐ง๐ ๐๐ฅ๐๐ฌ๐ญ๐ข๐๐ข๐ญ๐ฒ. ๐๐ก๐ฒ “๐๐จ๐ข๐ฌ๐” ๐ข๐ฌ ๐ญ๐ก๐ ๐๐๐๐ซ๐๐ญ ๐๐๐ฎ๐๐ ๐จ๐ ๐๐ฎ๐ฆ๐๐ง ๐๐ง๐ญ๐๐ฅ๐ฅ๐ข๐ ๐๐ง๐๐. ๐๐๐๐จ๐๐ข๐ง๐ ๐๐ง๐๐๐ซ๐ญ๐๐ข๐ง๐ญ๐ฒ: ๐๐ฌ๐ข๐ง๐ ๐๐ญ๐จ๐๐ก๐๐ฌ๐ญ๐ข๐ ๐๐ช๐ฎ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ญ๐จ ๐๐ง๐๐๐ซ๐ฌ๐ญ๐๐ง๐ ๐ญ๐ก๐ ๐๐ซ๐๐ข๐งโ๐ฌ ๐๐ก๐๐จ๐ฌ. In most engineering disciplines, “noise” is an enemy to be filtered out or minimized. However, in the human brain, noise is a fundamental feature of the […]
Posted in Regulatory Medical Writing Comments Off on ๐๐๐๐จ๐๐ข๐ง๐ ๐๐ง๐๐๐ซ๐ญ๐๐ข๐ง๐ญ๐ฒ: ๐๐ฌ๐ข๐ง๐ ๐๐ญ๐จ๐๐ก๐๐ฌ๐ญ๐ข๐ ๐๐ช๐ฎ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ญ๐จ ๐๐ง๐๐๐ซ๐ฌ๐ญ๐๐ง๐ ๐ญ๐ก๐ ๐๐ซ๐๐ข๐งโ๐ฌ ๐๐ก๐๐จ๐ฌ๐ ๐จ๐๐ฎ๐ฌ๐ข๐ง๐ ๐จ๐ง ๐๐๐ญ๐ญ๐๐ซ ๐๐ฅ๐ญ๐๐ซ๐ง๐๐ญ๐ข๐ฏ๐๐ฌ ๐ญ๐จ ๐ฌ๐ก๐ข๐ฉ๐ฉ๐ข๐ง๐ ๐จ๐๐ ๐๐ฅ๐๐๐ซ๐ฅ๐ฒ ๐ฉ๐๐ซ๐๐ง๐ญ๐ฌ ๐ญ๐จ ๐ง๐ฎ๐ซ๐ฌ๐ข๐ง๐ ๐ก๐จ๐ฆ๐๐ฌ
Posted by Michael A. S. Guth on April 2nd, 2026
๐ ๐จ๐๐ฎ๐ฌ๐ข๐ง๐ ๐จ๐ง ๐๐๐ญ๐ญ๐๐ซ ๐๐ฅ๐ญ๐๐ซ๐ง๐๐ญ๐ข๐ฏ๐๐ฌ ๐ญ๐จ ๐ฌ๐ก๐ข๐ฉ๐ฉ๐ข๐ง๐ ๐จ๐๐ ๐๐ฅ๐๐๐ซ๐ฅ๐ฒ ๐ฉ๐๐ซ๐๐ง๐ญ๐ฌ ๐ญ๐จ ๐ง๐ฎ๐ซ๐ฌ๐ข๐ง๐ ๐ก๐จ๐ฆ๐๐ฌ. Moira Welsh’sย HAPPILY EVER OLDERย is a hopeful investigative work that serves as a “blueprint for change” in long-term careย . Instead of focusing on common horror stories, Welsh travels across North America and Europe to find facilities that have successfully replaced institutional “warehousing” with vibrant […]
Posted in About, Regulatory Medical Writing Comments Off on ๐
๐จ๐๐ฎ๐ฌ๐ข๐ง๐ ๐จ๐ง ๐๐๐ญ๐ญ๐๐ซ ๐๐ฅ๐ญ๐๐ซ๐ง๐๐ญ๐ข๐ฏ๐๐ฌ ๐ญ๐จ ๐ฌ๐ก๐ข๐ฉ๐ฉ๐ข๐ง๐ ๐จ๐๐ ๐๐ฅ๐๐๐ซ๐ฅ๐ฒ ๐ฉ๐๐ซ๐๐ง๐ญ๐ฌ ๐ญ๐จ ๐ง๐ฎ๐ซ๐ฌ๐ข๐ง๐ ๐ก๐จ๐ฆ๐๐ฌ